|
5113.0: Wednesday, November 10, 2004: 12:30 PM-2:00 PM | |||
Oral | |||
| |||
This oral session will present finding from research studies examining the social consequences of stigma among drug users; explain factors related to the use of antiretroviral therapy among drug users; discuss the dynamics of injection drug users' personal networks; show findings about the association of alcohol consumption with risky behaviors; and examine factors behind the high prevalence of HIV among drug users in Nepal. | |||
Learning Objectives: To present research studies relevant to injection drug user and the HIV/AIDS epidemic. | |||
Leland J. Yee, PhD, MPH | |||
HIV positive drug users: Who uses HIV combination therapy? Marjorie F. Goldstein, PhD, Sung-Yeon Kang, PhD, Sherry Deren, PhD | |||
Social consequences of stigma and adherence to highly active antiretroviral therapy (HAART) among illegal drug users Norma C. Ware, PhD, Monique A. Wyatt, Toni Tugenberg, MEd, LICSW | |||
Dynamics of injection drug users' personal networks and HIV risk behaviors Elizabeth Costenbader, MS, Nan M. Astone, PhD | |||
Association of alcohol consumption with HIV-risky drug and sexual behaviors among injection drug users entering drug treatment Robert C. Freeman, PhD | |||
Factors behind the high prevalence of HIV among drug injectors in a border town of Nepal Binod Nepal, MA, Perti J Pelto, PhD, Laxmi Bilas Acharya, PhD, Anand Tamang, MPhil, Mahesh Shrestha, MSc, James L Ross, PhD | |||
See individual abstracts for presenting author's disclosure statement and author's information. | |||
Organized by: | HIV/AIDS | ||
Endorsed by: | Population, Family Planning, and Reproductive Health; Public Health Education and Health Promotion; Socialist Caucus | ||
CE Credits: | CME, Health Education (CHES), Nursing |